Boryung announced on the 10th that it signed a sales agreement with Baxter Korea to sell inhalation anesthesia ‘Suprane Solution (desflurane)’ and blood substitute ‘Plasma Lyte 148 Inj’ in the domestic market.

Suprane, developed by Baxter, is a premier inhalation anesthesia for inducing or maintaining anesthesia during surgery. It offers rapid and accurate control of the depth of anesthesia and has the lowest solubility among inhaled anesthetic, enabling fast and predictable patient recovery after anesthesia.

Plasma Lyte 148 Inj is an original fluid solution developed by Baxter. It is a physiologically balanced blood substitute with sodium, magnesium, and potassium levels similar to huma